Airway Management Devices Market is expected to surpass US$ 2.2 billion by 2033

 The Airway Management Devices Market is anticipated to be valued at US$ 1.6 billion in 2023, with total revenue recording a 3.6% CAGR from 2023 to 2033, reaching US$ 2.2 billion.

The airway management devices market was valued at US$ 1.5 billion in 2022, with a 3.2% CAGR expected throughout the projected period. The global market's absolute dollar growth is US$ 668.5 million.

The rising frequency of respiratory disorders is expected to be one of the market's key driving forces. The WHO estimates that 65 million people have moderate-to-severe COPD. Furthermore, COPD is expected to be the third biggest cause of death globally.

Get Full Access @ https://www.futuremarketinsights.com/reports/airway-management-devices-market

This high incidence, combined with an increase in anaesthetic consumption as a result of many surgeries, is likely to drive demand for advanced equipment, positively impacting the overall market growth. The growing demand for emergency treatment for long-term illnesses, as well as long-term therapy for lung disorders in children and adults, is also anticipated to fuel market expansion.


In the current scenario, growing awareness of inadequate ventilation and the introduction of relatively advanced procedures for preoperative airway examination are projected to broaden the possibility for product penetration in the future years. Preoperative Endoscopic Airway Evaluation (PEAE), for example, aids in the identification and prediction of blocked ventilation, as well as the design of an effective management strategy that focuses on the use of advanced equipment like supraglottic airway.

Key Takeaways

  • The market is estimated to drive due to increased demand for emergency and intensive care.
  • The rise in the prevalence of respiratory diseases is likely to drive the growth of the market for airway management devices.
  • The airway management devices market is expected to be worth US$ 1.6 billion in 2023.
  • Airway management devices market is forecasted to register a 3.6% CAGR from 2023 to 2033.
  • North America is likely to dominate the market for airway management devices market.

Recent Developments:

  • Verathon Inc. introduced the GlideScope Core 15 airway visualisation system in January 2020, which employs a 15-inch high-definition touchscreen monitor to provide improved visibility.
  • In January 2020, Smiths Medical, Inc. announced the expansion of its Portex Tracheostomy Tubes and Kits line by releasing a PVC-based tracheostomy tube range. The portfolio includes BLUperc, BLUselect tracheostomy tubes, and BLUgriggs percutaneous tracheostomy kits and trays.
  • Olympus Corporation, a global technology leader in inventing and delivering new solutions for surgical and medical procedures, among other core activities, announced the release of two video rhino-laryngoscopes in September 2019. It is proposed that the ENF-VH2/V4 be specially constructed for laryngological tests.
  • In September 2018, Royal Philips announced the development of a resuscitation device in conjunction with the Consortium for Affordable Medical Technologies (CAMTech) to aid in the reduction of infant mortality.
  • In January 2019, Oventus Medical, a medical device business, unveiled O2 Vent Optima, a new product. It is used to treat obstructive sleep apnea. It is based on the airway technology developed by Oventus Medical. It keeps the airway from contracting and allows for unrestricted airflow from the tongue, soft palate, and nose. It is suitable for usage with or without continuous positive airway pressure.

Key participants in the global market include:

  • Medtronic Plc
  • Teleflex Incorporated
  • Ambu A/S
  • Smith’s Group plc.
  • Intersurgical Ltd.
  • Cook Medical Inc.
  • SunMed
  • Vyaire Medical Inc
  • VBM Medizintechnik GmbH
  • Karl Storz SE & Co. KG
  • Cook Gas LLC
  • Flexicare (Group) Limited
  • BVLM Pty Ltd
  • Boston Medical Products Inc. (BESS GROUP)
  • Salter Labs

Airway Management Devices Market Key Segments

By Product Type:

  • Laryngeal Masks
  • Tracheostomy Tubes
  • Endotravheal Tubes
  • EndoBronhial Tubes
  • Nasal Airway Tubes
  • Oral Airway Tubes.

By Usage Type:

  • Single Use/ Disposable
  • Reusable

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more